Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia

Movement Disorders

Volumn 27, Issue 6, 2012, Pages 727-734

  Goldman, Jennifer G ^a   Stebbins, Glenn T ^a   Bernard, Bryan ^a   Stoub, Travis R ^a   Goetz, Christopher G ^a   deToledo Morrell, Leyla ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Cognition; Magnetic resonance imaging; Mesial temporal lobe; Parkinson's disease

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; AUTOPSY; BRAIN CORTEX ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DEMENTIA; DEPTH PERCEPTION; DISEASE DURATION; ENTORHINAL CORTEX; ENTORHINAL CORTEX ATROPHY; EXECUTIVE FUNCTION; FEMALE; HEMISPHERE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IN VIVO STUDY; LANGUAGE; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECALL; RECOGNITION; TASK PERFORMANCE;

AGED; AGED, 80 AND OVER; ATROPHY; DEMENTIA; DISEASE PROGRESSION; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; PARKINSON DISEASE;

EID: 84861686614     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.24938     Document Type: Article

References (69)

1. Louis ED, Marder K, Cote L, Tang M, Mayeux R. Mortality from Parkinson disease. Arch Neurol 1997; 54: 260-264.
2. Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 2000; 48: 938-942.
3. Hughes TA, Ross HF, Mindham RH, Spokes EG. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand 2004; 110: 118-123.
4. Levy G, Tang MX, Louis ED, et al. The association of incident dementia with mortality in PD. Neurology 2002; 59: 1708-1713.
5. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60: 387-392.
6. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008; 23: 837-844.
7. deToledo-Morrell L, Dickerson B, Sullivan M, Spanovic C, Wilson R, Bennett D. Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease. Hippocampus 2000; 2000: 136-142.
8. deToledo-Morrell L, Sullivan MP, Morrell F, Wilson RS, Bennett DA, Spencer S. Alzheimer's disease: in vivo detection of differential vulnerability of brain regions. Neurobiol Aging 1997; 18: 463-468.
9. Jack CR, Jr., Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997; 49: 786-794.
10. Killiany RJ, Hyman BT, Gomez-Isla T, et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 2002; 58: 1188-1196.
11. Stoub TR, Bulgakova M, Leurgans S, et al. MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology 2005; 64: 1520-1524.
12. Squire LR, Zola-Morgan S. The medial temporal lobe memory system. Science 1991; 253: 1380-1386.
13. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259.
14. Bobinski M, de Leon MJ, Wegiel J, et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience 2000; 95: 721-725.
15. Jack CR, Jr. Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002; 58: 750-757.
16. Gosche KM, Mortimer JA, Smith CD, Markesbery WR, Snowdon DA. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology 2002; 58: 1476-1482.
17. deToledo-Morrell L, Goncharova I, Dickerson BC, Wilson RS, Bennett DA. From healthy aging to early Alzheimer's disease: In vivo detection of entorhinal cortex atrophy. Ann N Y Acad Sci 2000; 911: 240-253.
18. deToledo-Morrell L, Stoub TR, Bulgakova M, et al. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging 2004; 25: 1197-1203.
19. Dickerson BC, Goncharova I, Sullivan MP, et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging 2001; 22: 747-754.
20. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-746.
21. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 263-269.
22. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 270-279.
23. Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA. Parkinson's disease is associated with hippocampal atrophy. Mov Disord 2003; 18: 784-790.
24. Tam CW, Burton EJ, McKeith IG, Burn DJ, O'Brien JT. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 2005; 64: 861-865.
25. Laakso MP, Partanen K, Riekkinen P, et al. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: an MRI study. Neurology 1996; 46: 678-681.
26. Junque C, Ramirez-Ruiz B, Tolosa E, et al. Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia. Mov Disord 2005; 20: 540-544.
27. Bouchard TP, Malykhin N, Martin WR, et al. Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease. Neurobiol Aging 2008; 29: 1027-1039.
28. Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004; 127: 791-800.
29. Bruck A, Kurki T, Kaasinen V, Vahlberg T, Rinne JO. Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. J Neurol Neurosurg Psychiatry 2004; 75: 1467-1469.
30. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004; 318: 121-134.
31. Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005; 64: 1404-1410.
32. Braak H, Braak E. Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles, and neuropil threads in the cerebral cortex. J Neural Transm Park Dis Dement Sect 1990; 2: 45-57.
33. Jellinger KA, Paulus W. Clinico-pathological correlations in Parkinson's disease. Clin Neurol Neurosurg 1992; 94( SUPPL): S86-S88.
34. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 2002; 59: 102-112.
35. Aarsland D, Perry R, Brown A, Larsen JP, Ballard C. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol 2005; 58: 773-776.
36. Kovari E, Gold G, Herrmann FR, et al. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Acta Neuropathol 2003; 106: 83-88.
37. Kenny ER, Burton EJ, O'Brien JT. A volumetric magnetic resonance imaging study of entorhinal cortex volume in dementia with lewy bodies. A comparison with Alzheimer's disease and Parkinson's disease with and without dementia. Dement Geriatr Cogn Disord 2008; 26: 218-225.
38. Lehmann M, Douiri A, Kim LG, et al. Atrophy patterns in Alzheimer's disease and semantic dementia: a comparison of FreeSurfer and manual volumetric measurements. NeuroImage 2010; 49: 2264-2274.
39. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50: 140-148.
40. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
41. Fahn S, Elton RL; the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. Florham Park, NJ: Macmillan Healthcare Information, 1987.
42. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427-442.
43. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010; 25: 2649-2653.
44. Hamilton M. Development of a rating scale for primary depressive illness. Brit Jrl Soc Clin Psych 1967; 6: 278-297.
45. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002; 59: 198-205.
46. Wilson R, Barnes L, Bennett D. Assessment of lifetime participation in cognitively stimulating activities. J Clin Exp Neuropsychol 2003; 25: 634-642.
47. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39: 1159-1165.
48. Weschler D. Weschler Adult Intelligence Scale-III. New York: The Psychological Corporation; 1991.
49. Smith A. Symbol Digits Modality Test. Los Angeles: Western Psychological Services; 1973.
50. Kaplan E, Goodglass, H, Weintraub, S. Boston Naming Test. Philadelphia: Lea & Febiger; 1983.
51. Benton A, Varney, N, Hamsher, K. Visuospatial judgment: a clinical test. Arch Neurol 1978; 35: 364-367.
52. Bourke J, Castleden CM, Stephen B, Dennis M. A comparison of clock and pentagon drawing in Alzheimer's disease. Int J Geriatr Psychiatry 1995; 10: 703-705.
53. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision, 4th ed. Washington, DC: American Psychiatric Association; 2000.
54. Goncharova II, Dickerson BC, Stoub TR, deToledo-Morrell L. MRI of human entorhinal cortex: a reliable protocol for volumetric measurement. Neurobiol Aging 2001; 22: 737-745.
55. Stoub TR, Rogalski EJ, Leurgans S, Bennett DA, deToledo-Morrell L. Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function. Neurobiol Aging 2010; 31: 1089-1098.
56. Higginson CI, Wheelock VL, Carroll KE, Sigvardt KA. Recognition memory in Parkinson's disease with and without dementia: evidence inconsistent with the retrieval deficit hypothesis. J Clin Exp Neuropsychol 2005; 27: 516-528.
57. Shi F, Liu B, Zhou Y, Yu C, Jiang T. Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: meta-analyses of MRI studies. Hippocampus 2009; 19: 1055-1064.
58. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22: 1689-1707; quiz, 1837.
59. Burton EJ, Mukaetova-Ladinska EB, Perry RH, Jaros E, Barber R, O'Brien JT. Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia. Neurobiol Aging 2011 Feb 23. doi: 10.1016/j.neurobiolaging.2010.12.015.
60. Hoops S, Nazem S, Siderowf AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009; 73: 1738-1745.
61. Apostolova LG, Beyer M, Green AE, et al. Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord 2010; 25: 687-688.
62. Beyer MK, Janvin CC, Larsen JP, Aarsland D. A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 2007; 78: 254-259.
63. Nagano-Saito A, Washimi Y, Arahata Y, et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 2005; 64: 224-229.
64. Wang WF, Wu SL, Liou YM, Wang AL, Pawlak CR, Ho YJ. MPTP lesion causes neuroinflammation and deficits in object recognition in Wistar rats. Behav Neurosci 2009; 123: 1261- 1270.
65. Sy HN, Wu SL, Wang WF, et al. MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus. Pharmacol Biochem Behav 2010; 95: 158-165.
66. Dickson DW, Fujishiro H, Orr C, et al. Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord 2009; 15( SUPPL 3): S1-S5.
67. Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson's disease. Mov Disord 2009; 24: 2175-2186.
68. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 1996; 93: 3908-3913.
69. Gerritsen L, Comijs HC, van der Graaf Y, Knoops AJ, Penninx BW, Geerlings MI. Depression, hypothalamic pituitary adrenal axis, and hippocampal and entorhinal cortex volumes-The SMART Medea Study. Biol Psychiatry 2011; 70: 373-380.